Dan Zenka, APR
Dan Zenka discusses why a man needs to understand his Gleason scores upon diagnosis of prostate cancer, as well as percentage of involvement in prostate gland. He addresses the importance of a patient having an in-depth discussion with his physicians to interpret the results.
Dan Zenka discusses the use of PSA (prostate-specific antigen) testing as a first-step diagnostic process for cancer. He addresses scoring and when it may be appropriate for a clinician to recommend a biopsy as the next step.
Dan Zenka discusses that there are more than 26 genotypes or varieties of prostate cancer. He addresses that there are some very slow growing, non life-threatening types, and some very aggressive types, and that a patient needs to look at all the treatment options that are available to them based upon testing and diagnosis.